Expanding Treatment Options: The Latest Developments in COPD - Episode 21
The MD Magazine Peer Exchange “Expanding Treatment Options: The Latest Developments in COPD Therapy” features a panel of physician experts discussing key topics in COPD therapy, including risk factors, personalized treatment, preventive measures, new combination therapies, and more.
This Peer Exchange is moderated by Peter Salgo, MD, professor of medicine and anesthesiology at Columbia University and an associate director of surgical intensive care at the New York-Presbyterian Hospital in New York City.
The panelists are:
Declining lung function is a major problem in COPD, and one of the only interventions that have been shown to slow down this decline is smoking cessation, said Hanania. Because a study of the decline in lung function would require a very long-term study with thousands of patients, this outcome is unfortunately not being tested.
Hanania also observed that the patients who have the fastest rate of decline are those with moderate COPD, not severe COPD. Similarly, patients with mild disease can also have frequent exacerbations, again pointing toward the importance of treating to the specific COPD phenotype.